[ERCC1 mRNA expression levels and outcome of gastric cancer patients receiving oxaliplatin-based chemotherapy]

Zhonghua Bing Li Xue Za Zhi. 2008 Aug;37(8):551-2.
[Article in Chinese]
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Drug Therapy, Combination
  • Endonucleases / genetics
  • Endonucleases / metabolism*
  • Female
  • Fluorouracil / pharmacology
  • Fluorouracil / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Organoplatinum Compounds / pharmacology*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • RNA, Messenger / drug effects*
  • RNA, Messenger / metabolism
  • Statistics as Topic
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / metabolism
  • Survival Analysis*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Organoplatinum Compounds
  • RNA, Messenger
  • Oxaliplatin
  • ERCC1 protein, human
  • Endonucleases
  • Fluorouracil